IPO Premiums
IPO calendar
DPDPLListed

Dipna Pharmachem Limited

Fixed Price IPO · BSE

Price band
₹38 - ₹38
Lot size
3,000 shares
Issue amount
₹15.21 cr
Total subscription
2.77×
Current price₹4.06
Listing price ₹32
Watch live price ↗
Opens
25 Aug 2022
Closes
30 Aug 2022
Allotment
5 Sept 2022
Listing
8 Sept 2022

Offer at a glance

Issue overview

Issue size
40,02,000 shares
Face value
₹10 per share
Minimum investment
₹1,14,000
Fresh issue
₹0 cr
Offer for sale
₹0 cr
Registrar
Bigshare Services Private Limited
Listing exchange
BSE
Maximum investment
₹1,14,000
Issue type
Fixed Price IPO
Shares before issue
79,68,000
Shares after issue
1,19,70,000

Lot sizes

CategoryLotsSharesAmount
RETAIL13,000₹1,14,000
HNI26,000₹2,28,000

Share reservation

Market Maker5.1%
NII (HNI)47.45%
RETAIL47.45%

Subscription & GMP

Subscription by category

Total subscribed2.77×

Subscription figures are awaiting publication.

GMP history

00.5127 Mar: ₹01 Dec: ₹0
27 Mar₹01 Dec

Financial performance

Company financials

In Lakhs · Reported periods may include interim results.

Revenue & profitIn Lakhs
02,0004,0006,0008,000Mar-22 · Revenue: 7,276.58Mar-22 · Profit after tax: 116.69Mar-22Mar-21 · Revenue: 3,101.54Mar-21 · Profit after tax: 2.42Mar-21Mar-20 · Revenue: 3,054.85Mar-20 · Profit after tax: 5.9Mar-20
RevenueProfit after tax

Company information

Company profile

Incorporated in 2011, Dipna Pharmachem Limited is involved in the trading and distribution of a wide range of pharmaceutical raw materials, including APIs, excipients, and chemical formulation products, and began selling chemicals on a commission basis in 2022. Operating in Ahmedabad and nearby regions, the company offers a portfolio of 61 APIs and intermediates covering categories like cephalosporins, cardiovascular, antibacterial, quinolones, veterinary, antiviral, anti-inflammatory, neuropsychiatry, and steroid hormones. It supplies essential raw materials to pharmaceutical industries, a sector recognized as an essential service by the Government.

Strengths

  • Diversified Product Portfolio: Offers a wide range of 61 APIs and intermediates across multiple therapeutic categories.
  • Experienced Promoter: Led by an industry expert with deep knowledge of pharmaceutical trading and distribution.
  • Quality Service: Committed to providing reliable and efficient supply of pharmaceutical raw materials.
  • High Customer Satisfaction: Strong focus on timely delivery and consistent quality , ensuring long-term client relationships.

Promoters

Mr. Keyur Dipakkumar Shah

Registrar & documents

Lead manager

Interactive Financial Services Limited

Registered office

A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad – 380 055,

+91-9898066121

[email protected]Company website ↗

Understanding DPL IPO data

Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.